Cerebras Systems posted $510m of revenue and $1.38 of earnings per share in the year to 31 December, then filed for a US initial public offering on 17 April. The Sunnyvale chipmaker, known for wafer-scale processors and a multi-year commercial relationship with OpenAI, plans to list on Nasdaq under the ticker CBRS. It refiled after withdrawing an earlier IPO and after a US national security review tied to investor G42 was cleared by the Committee on Foreign Investment in the United States in 2025.

Cerebras Systems has returned to the public market gate. The company filed a registration statement with the US Securities and Exchange Commission on 17 April, setting out financial results and governance details that will be central to investor scrutiny.

The filing shows revenue rose to $510m in the year ending 31 December. The company reported $1.38 in earnings per share for that period, versus a $9.90-per-share loss a year earlier. Cerebras said it plans to list on Nasdaq under the symbol CBRS.

What the company sells

Cerebras builds wafer-scale engine chips. The design is very different from the GPUs that dominate the market. The chips aim to avoid dependence on high-bandwidth off-chip memory, which Cerebras says can slow AI workloads.

The firm has emphasised inference, the stage when trained models generate answers for users. That focus mirrors a broader industry shift as more workloads move from training to deployment.

Customers, contracts and concentration

Cerebras has linked much of its sales growth to a long-term commercial relationship with OpenAI.

The filing notes a multi-year arrangement under which OpenAI will deploy Cerebras hardware.

The Reuters account of the filing said the deal was worth $20bn and would involve deployment of 750 megawatts of Cerebras chips. The contract is a major revenue anchor. It also underlines a dependency that investors will watch closely.

Mastheads

That point was underlined by Stacy Rasgon, a semiconductor analyst at Bernstein Research, who said the company was going public at a time when investor demand for AI infrastructure is high but so is scrutiny of unit economics. "Investors will want to see the path to diversified revenue streams beyond two anchor customers," Rasgon added.

Earlier fundraising and regulatory history are part of the story. Cerebras first filed with the SEC in 2024 but withdrew its offering after a large private capital round and a national security review related to G42, a United Arab Emirates-based technology group that had been an investor and a customer. The filing says Cerebras obtained clearance from the Committee on Foreign Investment in the United States in 2025.

Valuation and deal mechanics

Private-market valuations have moved quickly. Reuters recalled a prior fundraise that valued Cerebras at about $8bn after a more than $1bn round in 2024. Other recent financing in early 2026 pushed private valuation estimates higher, and market commentary has put a prospective IPO valuation range in the tens of billions.

The filing names Morgan Stanley, Citigroup, Barclays and UBS as lead underwriters. Those banks will guide pricing and allocation as the company tests investor demand for one of the most closely watched chip floats this year.

Bankers and issuers have cited stabilising market sentiment since a volatile spell in March. That volatility had slowed new listings, according to market commentary cited alongside the filing. The uptick in activity has encouraged other AI and semiconductor companies to consider public offerings while investor interest is fresh.

Who stands to gain or lose

Investors in AI infrastructure are the immediate audience for the offer. Portfolio managers hunting for exposure to generative AI and companies building model-serving capacity will weigh Cerebras’ growth against its customer concentration.

Customers that need large inference capacity could gain from new products and scale. Rival chipmakers, including much larger GPU suppliers, will face renewed competition in areas where inference demand is growing.

Employees and early investors will also be affected. A successful IPO would provide liquidity for private holders and expand the firm’s access to capital for product development and sales expansion.

Cerebras has indicated an intention to move over the next few months, though exact pricing and timing will depend on market conditions. The firm’s return to the IPO pipeline is one sign that underwriters and issuers see an opening for AI-related listings after recent turbulence.

That opening has attracted attention across venture-backed technology companies that had paused plans during the downturn. For now, Cerebras is a bellwether for investor appetite in AI infrastructure offerings.

Related Articles

Pricing and timing will be set by lead underwriters Morgan Stanley, Citigroup, Barclays and UBS as the company tests investor demand, with the OpenAI-linked contract central to assessments of revenue diversification.

This article was created with AI assistance.